May 19, 2026. 10 articles reviewed below the CED clinical relevance threshold of 35. Listed in descending order of score.
Erectile Dysfunction May Predispose Older Men to Multiple Types of Substance Abuse
This article examines associations between erectile dysfunction and substance abuse patterns in older men, potentially relevant for clinicians assessing polydrug use in elderly cannabis patients.
This topic comes up in consultations often.
Dr. Caplan offers clinical context on evolving cannabis policy and its real-world implications for patients.
Book a consultation →Voices of Cannabis Europa: Jonathan Havens and Adam Fayne, Partners at Saul Erwing
This article profiles cannabis industry partners discussing European institutional research opportunities and pharmaceutical development, potentially offering clinicians insights into international regulatory frameworks and research accessibility.
Read more →Vol. 72, No. 8, May 19, 2026 – Final Issue – Chiropractic Economics
Article Summary This article discusses the endocannabinoid system’s role in metabolism and health, plus Health Savings Account strategies for chiropractors—topics of tangential interest to clinicians studying cannabinoid physiology.
Read more →Recreational weed brings in nearly $300 million a year in taxes. What if a Mass. ballot …
Article discusses Massachusetts recreational marijuana tax revenue and a November ballot question that could eliminate it, potentially relevant to clinicians tracking policy impacts on cannabis availability and patient access.
Read more →Treatment delays rising among teens with cannabis use disorder – News-Medical.Net
Article Summary The article discusses cannabis use disorder treatment delays in adolescents and older adults’ edible consumption patterns for sleep, pain, and mood management.
Read more →Researchers Develop High-Temperature Stable Hemp-Derived Plastic from CBD
Summary Researchers created a thermally stable plastic material from hemp-derived CBD, demonstrating a non-medical application of cannabis compounds that may interest clinicians tracking industrial cannabinoid utilization trends.
Read more →Is Tenet (THC) a Buy as Wall Street Analysts Look Optimistic? – Yahoo Finance
The article discusses Wall Street analyst recommendations for Tenet (THC) stock, which may interest clinicians monitoring cannabis industry financial trends and market valuations.
Read more →In Business: Leech Lake Approves Band’s 1st Cannabis Cultivation Facility – Lakeland PBS
Leech Lake Band approved its first cannabis cultivation facility, representing tribal regulatory development and potential implications for indigenous cannabis commerce and governance structures.
Read more →Convicted felon arrested after officers find PCP, nearly 20 pounds of marijuana – KTLA
Summary for Cannabis Clinician Law enforcement arrested a convicted felon during a traffic stop in San Bernardino with substantial marijuana quantities, illustrating cannabis seizure patterns in illicit drug enforcement operations.
Read more →Vena Made a THC Seltzer for Coastal Girls That Will Absolutely Humble You – VICE
This article reviews a commercially available THC seltzer product, providing consumer feedback on potency and effects that may inform clinicians about market formulations and dosing presentations.
Read more →Digest-Level Clinical Commentary
These headlines reflect a field in transition where cannabis medicine is moving beyond anecdotal use toward legitimate clinical applications, particularly for older adults seeking alternatives to sedatives and opioids for pain and sleep, while simultaneously revealing persistent challenges around youth access, substance use disorder, and the need for rigorous treatment protocols. The commercial and legislative momentum, combined with emerging research on cannabinoid pharmacology and novel delivery systems, suggests the next phase of cannabis medicine will require practitioners like myself to navigate between evidence-based dosing and patient expectations shaped by a largely unregulated consumer market. What strikes me most is the urgent gap between clinical need—particularly in geriatric populations and those with complex pain syndromes—and our current training infrastructure, which remains inadequate for the volume of patients now asking about cannabis as a therapeutic option.
These items reflect several concurrent developments in cannabis use and policy: increasing normalization of cannabis products across diverse consumer demographics (including older adults seeking relief from pain and sleep disturbances), growing commercial infrastructure and tax revenue from legalized markets, and emerging research into both therapeutic applications and material science uses of cannabis compounds. The digest also suggests ongoing public health concerns, particularly regarding cannabis use disorder in younger populations and drug enforcement issues, indicating that regulatory expansion has not eliminated substance-related harms. Clinically, this landscape requires practitioners to develop competency in screening for cannabis use patterns across age groups, understanding the distinction between therapeutic and problematic use, and staying informed about evolving evidence on both risks and potential benefits.
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
FAQ
This News item was assembled from structured source metadata and pipeline scoring.
Have thoughts on this? Share it:
